No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditionsNone |
244368 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
396 |
4. Check minimum number of eventsNone |
396 |
5. Include endpointsNone |
396 |
6. Filter based on genotype QC (FinnGen only) |
350 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Seminoma of testis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of testis, including Hilmo
- malignant neoplasm of male genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 350 | - | 350 |
| Unadjusted period prevalence (%) | 0.16 | - | 0.16 |
| Median age at first event (years) | 37.68 | - | 37.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 371
- Matched controls
- 3710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
307.7
278
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
1059.5
306.9
260
8
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
278.5
231
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
697.0
239.2
212
7
JN4BD
NOMESCO Finland
Extensive body CT
35.6
216.2
152
71
JN4AD
NOMESCO Finland
Body CT examination
19.9
132.2
115
82
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.2
118.6
107
81
130
Kela drug reimbursment
Malignant tumour
+∞
115.9
105
*
A03FA01
ATC
metoclopramide; systemic, rectal
13.7
113.4
126
134
H02AB02
ATC
dexamethasone; systemic
59.8
98.8
56
11
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
87.0
80
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
72.3
67
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.6
61.0
41
15
A04AA01
ATC
ondansetron; systemic, rectal
21.8
53.6
41
21
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
52.3
49
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
52.3
49
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
51.2
48
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
559.4
50.7
49
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
45.8
43
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.9
44.8
79
140
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
41.4
39
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
36.0
34
*
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
34.9
33
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
34.9
33
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
34.9
33
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
369.3
34.5
34
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.7
34.0
170
684
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
33.9
32
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
32.4
221
1076
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
30.6
29
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
29.6
28
*
L03AA02
ATC
filgrastim; parenteral
112.4
29.1
31
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
28.8
82
219
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
27.4
26
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
27.4
26
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.6
26.2
72
186
N02AA05
ATC
oxycodone; systemic
4.5
24.9
69
179
WF002
NOMESCO Finland
Radical radiotherapy
+∞
24.2
23
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
255.8
23.9
24
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
23.6
116
446
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
22.8
71
201
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.6
22.3
27
30
E29.1
ICD-10 Finland
Testicular hypofunction
7.0
21.3
34
53
XX3DW
NOMESCO Finland
Time consuming IT work
6.6
20.7
35
58
C61
ICD-10 Finland
Malignant neoplasm of prostate
210.8
19.7
20
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
210.8
19.7
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.9
18
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
18.9
18
*
L01BC06
ATC
capecitabine; oral
+∞
17.9
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
99.9
17.7
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
16.8
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
16.8
16
*
ZXE00
NOMESCO Finland
One hour or less
2.6
16.2
141
716
Z51.5
ICD-10 Finland
Palliative care
7.0
16.0
25
38
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
15.7
15
*
N46
ICD-10 Finland
Male infertility
5.1
14.8
32
67
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
14.4
127
644
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
13.7
69
262
Y78
ICPC
Malign neopl male genital other
+∞
13.6
13
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
13.6
13
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
13.6
13
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
145.1
13.5
14
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
13.2
51
165
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
13.1
126
660
JN4CD
NOMESCO Finland
Very extensive body CT
16.2
12.8
20
13
WX320
NOMESCO Finland
Spinalanesthesy
2.6
12.6
84
370
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
12.6
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.6
12
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
12.6
12
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
12.5
24
45
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
11.6
21
37
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
11.5
11
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
11.5
11
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
36.3
11.3
14
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
25.9
11.2
15
6
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
61.8
10.7
12
*
WX402
NOMESCO Finland
General anaesthesia
2.4
10.6
84
399
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
10.5
10
*
ZX120
NOMESCO Finland
Intravenous
3.5
10.4
37
113
WW500
NOMESCO Finland
Blood transfusion
9.5
10.1
20
22
WZC30
NOMESCO Finland
Teaching
2.7
9.9
60
250
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
9.9
31
87
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
10.4
9.6
18
18
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
9.4
9
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
9.4
9
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
9.4
9
*
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.1
8.6
24
62
7513
FHL
Test prosthesis installation
92.1
8.4
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
92.1
8.4
9
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.9
8.4
17
20
9061/3-C62.0
ICD-O-3
Seminoma, NOS, of undescended testis
+∞
8.4
8
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
+∞
8.4
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
8.4
8
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
8.4
8
*
B01AB05
ATC
enoxaparin; parenteral
2.2
8.3
83
433
N02BE01
ATC
paracetamol; systemic, rectal
2.3
8.2
315
2618
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
46.0
7.7
9
*
R50.9
ICD-10 Finland
Fever, unspecified
2.3
7.6
65
316
Y05
ICPC
Scrotum/testis sympt/compl other
6.5
7.3
18
29
A04AD12
ATC
aprepitant; systemic
+∞
7.3
7
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
7.3
7
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
16.1
7.3
11
7
B01AB10
ATC
tinzaparin; parenteral
3.1
7.3
30
101
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.9
7.2
21
56
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
7.1
37
142
KF8AE, ,
SPAT
4.4
6.8
17
40
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.4
6.8
15
21
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
6.7
25
79
N02AA01
ATC
morphine; systemic, rectal
12.5
6.6
11
9
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.6
6.6
38
154
ZXA05
NOMESCO Finland
Left side
2.0
6.5
80
449
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
71.0
6.4
7
*
J01MA12
ATC
levofloxacin; systemic
2.2
6.4
59
296
Y28
ICPC
Limited function/disability (Y)
9.5
6.3
12
13
KA1FN
NOMESCO Finland
Isotope renography
18.4
6.3
9
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
6.3
60
305
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
1860A
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOPL MAL TESTIS (ABDOMIN/INGUIN),SEMINOMA]
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
6.3
6
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
6.3
6
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
6.3
6
*
KFB00
NOMESCO Finland
Biopsy of testis
27.2
6.3
8
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
190
33
116.96
307.65
8.2
2.4
83.23
3.12
u/ml
0.50
182
33
206
11
419.83
307.65
9.4
1.1
16.39
—
u/l
—
56
0
87
48
23.37
112.36
3.8
1.4
16.96
7.93
iu/l
2.41
73
33
100
7
194.65
99.80
9.8
1.0
5.85
—
pmol/l
—
60
0
117
138
11.92
97.13
3.3
1.5
7.77
3.92
u/l
3.44
101
116
259
1540
3.26
24.67
12.4
8.0
3.76
4.26
e9/l
2.95
230
1361
24
5
51.10
20.41
6.9
2.4
3.25
4.00
ug/l
—
24
5
149
714
2.82
20.02
5.6
2.1
2.36
2.34
mmol/l
1.24
141
643
47
107
4.88
19.80
6.8
2.0
4.00
2.52
ug/l
1.31
41
84
96
374
3.11
18.65
5.5
1.9
2.44
2.42
mmol/l
1.14
86
323
152
787
2.58
16.93
4.2
2.9
87.41
124.21
e6/l
0.14
121
603
136
675
2.60
16.46
4.1
2.8
0.57
0.27
e6/l
0.38
107
494
176
1017
2.39
15.00
2.9
2.5
—
—
estimate
—
0
0
95
416
2.73
14.57
3.7
2.6
1.06
1.11
e6/l
0.03
62
215
90
389
2.73
14.12
4.0
2.6
0.38
0.48
e6/l
0.26
56
186
177
1082
2.22
12.59
9.7
4.6
36.58
36.84
g/l
0.23
165
1011
234
1616
2.21
12.04
6.1
5.5
6.70
6.87
mmol/l
0.45
223
1548
187
1193
2.14
11.67
12.5
7.4
1.20
1.20
mmol/l
0.23
152
1059
165
1054
2.02
9.77
10.8
7.1
1.21
1.20
mmol/l
1.09
160
984
104
589
2.06
8.37
1.8
1.8
1.06
0.95
mg/l
0.19
78
431
20
48
4.35
7.83
2.0
3.4
36.95
44.85
%
0.86
20
48
20
48
4.35
7.83
4.1
6.8
10.25
8.25
%
0.70
20
48
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
76
3.45
7.10
4.2
3.3
0.29
0.34
iu/ml
0.43
13
39
58
278
2.29
7.03
2.6
2.0
204.93
244.29
pmol/l
1.67
58
265
22
63
3.65
6.82
1.4
1.4
168.75
130.50
au/ml
—
8
14
330
2858
2.40
6.76
22.7
11.3
86.30
88.29
ml/min/173m2
0.75
312
2618
31
113
2.90
6.56
1.6
1.7
240.04
256.77
mu/l
0.23
31
106
88
531
1.86
5.67
3.3
2.2
—
—
—
0
0
71
401
1.95
5.58
11.5
8.7
103.80
104.26
mmol/l
0.43
71
401
48
238
2.17
5.34
3.4
2.9
—
—
—
0
0
334
2971
2.25
5.34
24.5
14.8
139.48
139.77
mmol/l
1.60
328
2922
333
2959
2.22
5.34
22.0
12.3
24.25
24.92
mg/l
0.13
281
2363
16
44
3.76
5.26
3.0
2.5
—
567.17
—
0
6
19
59
3.34
5.24
1.7
1.4
285.67
307.25
ug/g
—
9
34
180
1355
1.64
5.15
3.6
3.1
0.03
0.00
estimate
0.49
37
263
181
1368
1.63
5.07
3.6
3.1
0.00
0.00
estimate
-0.00
35
228
334
2984
2.20
5.07
24.9
14.8
4.02
4.01
mmol/l
0.38
327
2931
178
1344
1.62
4.98
3.6
3.0
0.00
0.00
estimate
-0.00
38
262
70
409
1.88
4.95
4.3
2.5
12.57
14.29
umol/l
1.16
63
382
65
385
1.83
4.39
4.4
2.5
2.23
2.23
g/l
0.04
60
359
15
39
3.96
4.24
1.4
1.6
—
—
—
0
0
60
353
1.83
4.13
4.7
2.5
23.01
24.91
%
0.62
55
331
110
767
1.62
4.10
3.8
2.4
365.77
379.78
umol/l
0.87
104
699
12
26
4.73
4.09
1.2
1.1
—
—
—
0
0
8
10
8.15
4.08
1.4
2.6
—
—
—
0
0
33
160
2.17
3.90
1.7
1.5
—
—
—
0
0
114
815
1.58
3.79
3.2
2.6
0.00
0.00
estimate
-0.00
30
214
210
1717
1.51
3.74
4.4
3.5
1.66
1.57
ug/l
0.24
186
1570
20
79
2.62
3.69
1.3
1.2
303.75
293.71
u/ml
0.05
12
52
31
155
2.09
3.41
1.5
1.5
—
—
—
0
0
50
296
1.80
3.38
4.3
2.6
8.64
10.13
umol/l
0.21
42
265
13
43
3.10
3.28
2.5
1.5
—
—
—
0
0
28
137
2.13
3.26
2.0
1.5
—
—
—
0
0
141
1091
1.47
3.14
3.4
2.9
0.00
0.00
estimate
-0.00
35
227
44
260
1.79
3.00
4.4
2.4
29.08
222.13
u/l
0.53
36
220
15
58
2.65
2.91
3.9
2.4
133.70
137.57
g/l
—
10
47
28
145
2.01
2.83
2.7
1.5
—
—
—
0
0
5
6
8.42
2.75
1.2
1.2
12.60
10.58
u/l
—
5
6
23
112
2.12
2.73
3.0
3.0
4.39
4.69
pmol/l
0.52
18
100
234
2022
1.43
2.73
4.2
3.9
11.78
8.83
mm/h
1.70
217
1920
37
216
1.79
2.64
2.8
2.1
0.19
0.30
e6/l
0.67
37
207
17
74
2.36
2.62
1.6
1.4
6.96
6.93
g/l
0.03
17
63
17
74
2.36
2.62
1.6
1.4
3.40
3.53
g/l
0.26
17
63
17
74
2.36
2.62
1.6
1.4
4.01
4.21
g/l
0.68
17
63
36
209
1.80
2.61
2.8
2.1
61.35
70.95
ml/min/173m2
0.46
17
82
62
420
1.57
2.54
2.9
1.7
—
—
—
0
0
113
872
1.43
2.46
3.3
2.7
56.62
63.50
u/l
0.60
103
833
5
8
6.32
2.38
1.6
1.4
—
—
—
0
0
16
71
2.31
2.38
1.6
1.4
2.92
2.76
g/l
0.21
16
60
28
155
1.87
2.37
1.8
1.8
64.48
67.84
g/l
1.55
28
140
7
19
3.73
2.16
4.4
1.9
—
—
—
0
0
5
10
5.05
2.07
2.0
2.3
0.62
0.61
mmol/l
—
5
10
46
308
1.56
2.00
7.4
3.3
1.23
1.64
mmol/l
0.37
41
264
6
16
3.79
1.94
1.5
1.2
—
—
—
0
0
96
751
1.38
1.89
3.0
3.3
954.67
1352.80
ng/l
0.83
80
616
9
34
2.69
1.87
1.3
1.4
—
—
—
0
0
31
192
1.67
1.85
8.1
3.3
23.48
24.28
mmol/l
0.90
31
192
7
23
3.08
1.80
3.4
1.4
—
—
—
0
0
46
317
1.51
1.77
7.4
3.3
5.92
5.84
kpa
0.20
46
308
7
24
2.95
1.73
1.4
1.3
—
—
—
0
0
5
13
3.88
1.72
1.6
1.2
—
—
—
0
0
5
14
3.60
1.62
1.6
1.2
—
—
—
0
0
5
14
3.60
1.62
1.4
1.1
—
—
—
0
0
5
14
3.60
1.62
1.6
1.2
—
—
—
0
0
13
63
2.10
1.61
2.6
1.4
—
—
—
0
0
13
63
2.10
1.61
2.6
1.5
—
—
—
0
0
7
26
2.72
1.59
3.4
1.5
—
—
—
0
0
15
78
1.96
1.56
3.6
1.6
—
—
—
0
0
8
33
2.45
1.54
1.9
1.6
—
—
—
0
0
120
999
1.30
1.52
2.8
2.4
0.71
0.67
ug/l
0.24
74
520
12
58
2.10
1.51
1.9
1.3
9.68
10.44
g/l
0.51
12
47
88
704
1.33
1.48
3.2
3.1
0.00
0.02
estimate
0.68
34
243
351
3385
1.69
1.48
35.0
17.9
4.68
4.81
e12/l
4.60
346
3327
10
45
2.26
1.47
1.9
1.3
0.00
0.00
g/l
—
10
40
11
52
2.15
1.46
1.1
1.2
—
—
—
0
0
45
323
1.45
1.45
11.2
11.6
0.48
1.25
mmol/l
0.89
37
271
5
16
3.15
1.44
1.6
1.2
—
—
—
0
0
12
60
2.03
1.39
1.5
1.6
—
—
—
0
0
6
24
2.52
1.31
1.2
1.1
—
—
—
0
0
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
5
18
2.80
1.29
14.0
3.4
0.40
0.94
index
—
5
18
50
375
1.39
1.28
1.9
1.8
1013.68
1189.95
nmol/l
0.89
36
308
131
1124
1.26
1.28
2.0
1.9
97.32
94.92
pmol/l
0.26
77
643
25
163
1.57
1.27
4.9
3.1
0.36
1.94
mmol/l
1.32
19
112
21
131
1.64
1.26
4.8
3.0
23.96
25.04
mmol/l
0.87
21
125
8
36
2.25
1.25
1.3
1.4
—
—
—
0
0
27
392
0.66
1.24
1.1
1.3
3.86
7.65
u/ml
—
7
158
5
19
2.65
1.22
1.8
1.7
—
—
—
0
0
36
257
1.44
1.21
6.7
2.8
5.54
4.53
kpa
1.56
36
249
71
568
1.31
1.20
2.6
2.1
2.92
2.80
mg/l
0.16
61
492
0
33
0.00
1.16
0.0
1.4
—
350.00
—
0
5
5
20
2.52
1.15
3.6
1.3
—
—
—
0
0
5
20
2.52
1.15
3.6
1.3
—
—
—
0
0
5
20
2.52
1.15
3.6
1.3
—
—
—
0
0
13
73
1.81
1.12
2.4
1.5
—
—
—
0
0
7
34
2.08
1.03
1.0
1.2
—
—
—
0
0
19
123
1.57
1.01
5.4
8.4
1.83
1.59
%
0.27
19
116
9
49
1.86
0.99
1.8
1.3
—
—
—
0
0
9
49
1.86
0.99
1.8
1.3
—
—
—
0
0
127
1114
1.21
0.98
3.7
3.3
59.70
53.41
ng/l
0.07
89
739
12
69
1.76
0.97
1.7
1.2
—
—
—
0
0
16
243
0.64
0.94
1.1
1.7
0.35
0.32
mg/l
—
5
141
6
27
2.24
0.94
3.7
2.3
0.51
0.78
e9/l
—
6
27
25
176
1.45
0.93
4.0
2.5
0.62
0.60
%
0.12
25
176
9
52
1.75
0.93
1.0
1.1
—
—
—
0
0
6
29
2.09
0.89
1.0
1.1
—
—
—
0
0
54
660
0.79
0.87
1.4
1.3
6.36
1.06
u/ml
0.61
16
220
42
329
1.31
0.85
2.9
1.7
—
—
—
0
0
6
31
1.95
0.84
1.5
1.0
—
—
—
0
0
6
31
1.95
0.84
2.7
2.4
1.19
1.18
mmol/l
—
6
31
6
31
1.95
0.84
2.7
2.4
105.17
105.35
mmol/l
—
6
31
8
46
1.76
0.83
7.0
4.8
19.23
14.39
pmol/l
—
8
46
35
448
0.76
0.81
1.3
1.2
12.48
25.43
iu/ml
—
10
133
6
33
1.83
0.79
2.7
4.0
—
—
—
0
0
6
33
1.83
0.79
1.8
1.7
—
—
—
0
0
39
306
1.31
0.79
3.9
4.4
31.00
28.92
%
0.49
29
224
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
40
317
1.29
0.76
3.0
1.8
—
—
—
0
0
9
54
1.68
0.75
1.0
1.7
—
—
—
0
0
272
2841
0.84
0.75
4.7
4.4
6.00
6.03
mmol/l
0.13
246
2654
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
15
100
1.52
0.74
1.3
1.6
—
—
—
0
0
7
38
1.86
0.74
1.1
1.1
—
—
—
0
0
12
76
1.60
0.72
1.3
1.1
—
—
—
0
0
12
77
1.58
0.69
1.3
1.1
—
—
—
0
0
298
3081
0.83
0.68
4.8
4.7
1.28
1.27
mmol/l
0.11
281
2936
5
28
1.80
0.66
1.0
1.1
257.60
276.22
mg/l
—
5
23
26
198
1.34
0.66
2.5
3.4
89.54
190.76
ng/l
2.11
26
178
13
189
0.68
0.65
1.5
1.7
—
—
—
0
0
302
3114
0.84
0.63
5.1
5.3
2.77
2.80
mmol/l
0.17
289
2969
285
2952
0.85
0.62
4.1
4.1
1.44
1.41
mmol/l
0.27
266
2801
147
1350
1.15
0.62
3.3
3.2
22.66
23.73
%
0.38
62
487
300
3091
0.85
0.59
4.8
4.8
4.60
4.58
mmol/l
0.08
283
2959
0
23
0.00
0.58
0.0
1.9
—
0.29
—
0
6
35
284
1.26
0.58
6.5
6.7
—
—
—
0
0
5
87
0.57
0.57
1.0
1.1
—
3.42
—
0
13
9
60
1.51
0.54
1.0
1.1
—
99.36
—
0
16
125
1147
1.14
0.53
4.3
2.6
185.36
159.34
ug/l
0.73
114
1084
73
647
1.16
0.50
3.1
3.3
1.02
1.02
kg/l
0.81
48
416
74
658
1.16
0.49
1.7
1.6
19.25
18.64
nmol/l
0.14
64
570
18
138
1.32
0.46
3.7
3.0
—
—
—
0
0
207
1970
1.11
0.46
3.9
3.0
14.87
14.82
pmol/l
0.11
187
1826
12
87
1.39
0.42
1.5
2.8
16.28
10.95
mg/l
0.74
12
82
0
15
0.00
0.41
0.0
1.0
—
6.41
—
0
15
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
9
68
1.33
0.38
1.4
1.5
111.90
186.17
pmol/l
—
9
68
6
44
1.37
0.34
1.2
1.3
—
—
—
0
0
51
455
1.14
0.34
2.2
2.2
—
—
—
0
0
43
379
1.15
0.34
1.7
1.7
3.79
3.67
mmol/l
0.20
26
275
277
2838
0.91
0.33
6.6
5.9
38.73
39.35
mmol/mol
0.55
257
2722
13
101
1.30
0.32
3.1
3.6
22.58
24.99
mmol/l
1.43
13
95
8
64
1.26
0.27
1.6
1.5
—
—
—
0
0
66
610
1.10
0.26
1.5
1.5
—
—
—
0
0
117
1111
1.08
0.25
3.1
2.4
72.80
71.56
nmol/l
0.18
108
1029
12
96
1.26
0.25
1.2
1.3
—
—
—
0
0
53
577
0.90
0.24
3.6
3.9
247.78
887.97
ng/l
1.73
41
436
9
77
1.17
0.24
1.1
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
11
0.00
0.21
0.0
3.0
—
131.09
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
1.07
—
0
13
25
221
1.14
0.20
1.2
1.4
—
—
—
0
0
16
136
1.18
0.20
1.1
1.0
—
—
—
0
0
6
49
1.23
0.20
1.3
1.2
—
—
—
0
0
6
52
1.16
0.19
1.2
1.3
—
—
—
0
0
6
53
1.13
0.19
1.3
1.3
—
—
—
0
0
15
128
1.18
0.18
4.1
2.9
—
—
—
0
0
7
59
1.19
0.18
1.7
1.2
—
—
—
0
0
53
496
1.08
0.17
2.2
2.2
—
—
—
0
0
16
182
0.87
0.15
7.9
9.4
24.14
24.43
mmol/l
0.16
16
177
55
518
1.07
0.15
1.7
1.8
419.20
34430232.51
pmol/l
0.69
44
456
122
1258
0.95
0.13
2.0
1.9
1.61
1.53
mmol/l
0.40
101
1095
54
512
1.06
0.13
1.9
2.0
3.64
4.04
ratio
1.07
39
411
217
2133
1.04
0.12
2.9
3.1
—
—
—
0
0
19
207
0.91
0.10
1.1
1.1
1.31
1.40
g/l
1.45
19
207
106
1085
0.97
0.08
3.7
4.1
8.77
9.23
mmol/l
0.44
87
962
7
83
0.84
0.07
1.3
1.3
—
—
—
0
0
20
211
0.94
0.04
1.1
1.1
1.01
0.96
g/l
0.36
20
211
85
863
0.98
0.03
2.6
2.2
134.89
333.43
u/l
1.60
85
823
239
2378
1.01
0.02
3.5
3.5
53.69
47.95
u/l
0.42
229
2292
14
133
1.05
0.01
1.3
1.2
—
—
—
0
0
256
2566
0.99
0.00
4.5
3.7
1.88
1.89
mu/l
0.06
232
2390
11
112
0.98
0.00
2.8
2.2
5.62
4.98
iu/ml
—
5
31
10
101
0.99
0.00
2.8
4.2
—
—
—
0
0
10
101
0.99
0.00
1.9
1.8
17.74
15.83
u/ml
—
5
33
94
943
1.00
0.00
4.7
4.7
9.02
9.55
mg/mmol
0.05
62
647
6
62
0.97
-0.00
1.0
1.4
—
630.00
—
0
6
0
8
0.00
-0.00
0.0
10.0
—
10.84
—
0
8
6
63
0.95
-0.00
1.3
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
1.25
—
0
7
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
16.88
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
5.04
—
0
5
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
-0.00
0.0
1.3
—
75.57
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_TESTIS_SEMINOMA_WIDE – Seminoma of testis, including Hilmo
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).